This course has expired. View available courses.
Diabetes, Endocrinology
Intensifying Therapy – GP Case (Latin America)
Type 2 diabetes is a common condition managed in primary care. Although clinical practice guidelines recommend specific targets for blood pressure, LDL-C and A1C, primary care research has demonstrated only a small portion of patients with type 2 diabetes are meeting these targets. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes 2021 recommends that patients meet glycemic targets, but there is an increased focus on selecting antihyperglycemic agents that can improve outcomes in patients with diabetes.
This module will focus on providing recommendations on the intensification of antihyperglycemic therapy beyond metformin in people with type 2 diabetes.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
DURATION
30 min
PROFESSION
Physician, Nursing, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-02-08
Type 2 diabetes is a common condition managed in primary care. Although clinical practice guidelines recommend specific targets for blood pressure, LDL-C and A1C, primary care research has demonstrated only a small portion of patients with type 2 diabetes are meeting these targets. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes 2021 recommends that patients meet glycemic targets, but there is an increased focus on selecting antihyperglycemic agents that can improve outcomes in patients with diabetes.
This module will focus on providing recommendations on the intensification of antihyperglycemic therapy beyond metformin in people with type 2 diabetes.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
Roopa Mehta, MBBS, MRCP
Graciela Alexanderson, MD, MACP
Learning objectives
Upon successful completion of this continuing education module, the participant will be better able to:
- Apply the American Diabetes Association (ADA) Standards of Medical Care in Diabetes 2021 treatment algorithm for managing people with type 2 diabetes
- Discuss the selection of antihyperglycemic agents in patients with cardiovascular and chronic kidney disease
- Individualize antihyperglycemic therapy based on the preferences of the person with diabetes